Myth #1: Biotech start-ups struggle with fundraising
Venture capitalist fundraising is difficult irrespective of the sector. "With a good product and a great team backing it, you become an attractive incubation target. There are a number of 'healthcare only' funds made available for life science start-ups," says Dr Mallik Sundaram, co-founder of Mitra Biotech.
Investors shy away from Life Sciences start-ups because of the widespread notion that investments in this field are risky with long gestation periods.